芮
芮晨为 Cadre supérieur
Other
FR FR · AMF
Discover the detailed record of transactions filed by 芮晨为, Cadre supérieur. Officer active across 1 companies, notably 南微医学. Aggregated, 36 filings have been recorded. Regulator: AMF. The full history is openly available.
Declarations 36 total
20,000 shares
SSE:273000000597979940 · 8 May 2026
10,000 shares
SSE:273000000229705500 · 3 Mar 2026
13,000 shares
SSE:273000000229705630 · 3 Mar 2026
20,600 shares
SSE:273000000229705600 · 2 Mar 2026
3,000 shares
SSE:273000000229705400 · 2 Mar 2026
Executives ● Sale聚 聚和材料 23 SSE 101,600 shares
SSE:273000000371938050 · 2 Mar 2026
8,000 shares
SSE:273000000229705340 · 2 Mar 2026
200 shares
SSE:273000000229711840 · 19 Jan 2026
5,000 shares
SSE:173000009663804770 · 23 Oct 2025
Executives ● Purchase聚 聚和材料 8 SSE 746 shares
SSE:173000007168902080 · 13 Dec 2023
Ideal exit: 8 Sept 2024 (T+270) 250,000 shares
SSE:173000007143192580 · 1 Dec 2023
Executives ● Purchase成 成大生物 11 SSE 5,000 shares
SSE:173000006468970340 · 11 Apr 2023
Ideal exit: 6 Jan 2024 (T+270) Executives ● Purchase成 成大生物 7 SSE 13,200 shares
SSE:173000006468970300 · 11 Apr 2023
Ideal exit: 6 Jan 2024 (T+270) Executives ● Purchase神 神火股份 7 SZSE 2,200 shares
SZSE:173000006441830900 · 31 Mar 2023
Ideal exit: 26 Dec 2023 (T+270) 346,700 shares
SSE:173000006419731740 · 29 Mar 2023
30,800 shares
SSE:173000006402427900 · 27 Mar 2023
427,100 shares
SSE:173000006396974820 · 24 Mar 2023
Executives ● Sale开 开立医疗 7 SZSE 200,000 shares
SZSE:173000005934830620 · 30 Sept 2022
Executives ● Purchase南 南微医学 2 SSE 2,052 shares
SSE:173000005804796800 · 23 Aug 2022
Ideal exit: 20 May 2023 (T+270) 2,380,000 shares
SSE:173000005730496420 · 28 Jul 2022
150,000 shares
SSE:173000005605513150 · 16 Jun 2022
Executives ● Purchase南 南微医学 11 SSE 8,400 shares
SSE:173000005457335900 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) Executives ● Purchase南 南微医学 7 SSE 12,600 shares
SSE:173000005457335940 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) 134,500 shares
SSE:173000005188422140 · 22 Dec 2021
Executives ● Purchase南 南微医学 11 SSE 6,750 shares
SSE:173000005457335970 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) 25 of 36 declarations
Load more (11 remaining) About 芮晨为 芮晨为 is a Senior Executive at 南微医学. In this role, he is responsible for managing operations and implementing the company's strategies. 南微医学 is an innovative company in the medical sector, and 芮晨为's expertise is crucial for its development.